Ad claims found unsubstantiated

legal law case justice crime
AFT Pharmaceuticals has again suffered disappointment in the Federal Court over advertising for Maxigesic, which was found to be misleading AFT Pharmaceuticals contended that its claims that Maxigesic had superior efficacy to other paracetamol-ibuprofen combinations, but Reckitt Benckiser, manufacturer of competitor Nuromol, had begun legal action over these advertising claims. AFT was seeking to re-open

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacy staff fail to detect CM harm
Next ‘Pharmacists are in handcuffs’ in disability care